Načítá se...
miR‐505 inhibits proliferation of osteosarcoma via HMGB1
Osteosarcoma is a malignant bone tumor, and clinically detectable metastases can be detected in ~ 15–20% of patients when they seek medical advice; patients with metastatic disease have extremely poor prognosis. Here, we examined the involvement of the microRNA miR‐505 in osteosarcoma. Eighty‐four p...
Uloženo v:
| Vydáno v: | FEBS Open Bio |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7327918/ https://ncbi.nlm.nih.gov/pubmed/32348630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12868 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|